Form 4: Cumberland Pharmaceuticals Director Increases Stake Through Pre-Scheduled Stock Purchases
Insider Trading Report
Cumberland Pharmaceuticals Inc. Director James Jones acquired additional common stock shares through a pre-arranged Rule 10b5-1 trading plan during June 2025.
Summary
- Director James Jones of Cumberland Pharmaceuticals Inc. (CPIX) acquired a total of 168 shares of common stock.
- The purchases occurred daily from June 2, 2025, to June 30, 2025.
- These transactions were executed under a Rule 10b5-1 trading plan that was established on November 14, 2024.
- The acquisition prices for the shares ranged from a high of $5.94 to a low of $2.60 per share.
- Following these transactions, James Jones beneficially owns 43,336 shares of CPIX common stock.
Sentiment
Score: 6
Explanation: While insider buying is generally a positive signal of management confidence, the significant decline in the stock price during the purchase period introduces a notable negative aspect. The Rule 10b5-1 plan indicates the purchases were pre-scheduled, which mitigates the immediate signal compared to discretionary buying.
Positives
- Insider buying by a director generally indicates confidence in the company's future prospects.
- The purchases were made under a Rule 10b5-1 plan, which signifies a pre-planned investment strategy and not a reaction to immediate non-public information.
Negatives
- The share price of CPIX common stock experienced a significant decline during the period of the director's purchases, falling from $5.20 on June 2, 2025, to $2.74 on June 30, 2025.
Future Outlook
No specific future outlook or guidance is provided in this Form 4 filing.
Industry Context
This Form 4 filing, detailing insider stock purchases, does not provide specific industry context or trends.
Related Party Transactions
- The reported transactions are related party dealings as they involve a director of the company purchasing company stock.
Stakeholder Impact
- Shareholders: The director's increased stake could be viewed as a positive signal of confidence in the company's long-term value, despite the short-term decline in share price during the purchase period.
Key Dates
| Date | Description |
|---|---|
| 2024-11-14 | Date Rule 10b5-1 trading plan was adopted by James Jones. |
| 2025-06-02 | Earliest transaction date for common stock acquisition. |
| 2025-06-03 | Transaction date for common stock acquisition. |
| 2025-06-04 | Transaction date for common stock acquisition. |
| 2025-06-05 | Transaction date for common stock acquisition. |
| 2025-06-06 | Transaction date for common stock acquisition. |
| 2025-06-09 | Transaction date for common stock acquisition. |
| 2025-06-10 | Transaction date for common stock acquisition. |
| 2025-06-11 | Transaction date for common stock acquisition. |
| 2025-06-12 | Transaction date for common stock acquisition. |
| 2025-06-13 | Transaction date for common stock acquisition. |
| 2025-06-16 | Transaction date for common stock acquisition. |
| 2025-06-17 | Transaction date for common stock acquisition. |
| 2025-06-18 | Transaction date for common stock acquisition. |
| 2025-06-20 | Transaction date for common stock acquisition. |
| 2025-06-23 | Transaction date for common stock acquisition. |
| 2025-06-24 | Transaction date for common stock acquisition. |
| 2025-06-25 | Transaction date for common stock acquisition. |
| 2025-06-26 | Transaction date for common stock acquisition. |
| 2025-06-27 | Transaction date for common stock acquisition. |
| 2025-06-30 | Latest transaction date for common stock acquisition. |
| 2025-07-11 | Signature date of the reporting person's attorney-in-fact. |
Recommendation
holdKeywords
Cumberland Pharmaceuticals, CPIX, James Jones, Insider Trading, Form 4, Stock Purchase, Director, Rule 10b5-1 Plan, Equity Acquisition, Pharmaceuticals
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.